Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTAIN: Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
NCT06696820Phase 3Completed
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of evolocumab in ischemic stroke. Started Nov 2024; status: completed.
02
Drugs
evolocumab
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06696820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06696820.